{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:18Z","timestamp":1786984278884,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Pulmonary sarcomatoid carcinoma (PSC) is a rare and aggressive subtype of non\u2013small-cell lung cancer. Marked histologic heterogeneity, nonspecific imaging findings, and limited representation in small biopsy specimens can cause diagnostic error, particularly when a pulmonary lesion abuts the anterior mediastinum and mimics a thymic tumor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 67-year-old woman presented to a local hospital in Hangzhou with chest pain, low-grade fever, and intermittent hemoptysis. Imaging showed a mass abutting the anterior mediastinum and adjacent lung parenchyma. Core needle biopsy showed predominantly spindle cells with few atypical epithelioid cells in a lymphocyte-rich background and was interpreted as thymic carcinoma. She was subsequently transferred to Zhejiang Hospital for further evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Continued progression during docetaxel\u2013cisplatin chemotherapy and persistent diagnostic uncertainty prompted video-assisted thoracoscopic wedge resection. The resected tumor showed markedly atypical spindle cells, pan-cytokeratin and vimentin positivity, thyroid transcription factor 1 negativity, and an elevated Ki-67 proliferation index. Programmed death-ligand 1 testing showed a tumor proportion score of approximately 10% and a combined positive score of approximately 20%. KRAS p.A146T and NRAS p.Q61K mutations were identified. Integrated histomorphologic, immunohistochemical, and molecular assessment established the diagnosis of PSC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient initially received docetaxel plus cisplatin. Because of continued disease progression, declining performance status, and myelosuppression and gastrointestinal adverse effects during platinum-based chemotherapy, cisplatin was discontinued. The patient subsequently received dose-reduced docetaxel plus pembrolizumab as an individualized treatment strategy intended to balance continued systemic therapy with tolerability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The disease progressed rapidly with metastases to the lungs, bone, soft tissue, liver, pancreas, and adrenal gland. The patient died of respiratory failure secondary to widespread tumor dissemination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>PSC should be considered when an apparent anterior mediastinal mass shows spindle cell morphology or discordant clinicoradiologic and pathologic findings. Adequate representative tissue and integrated radiologic, morphologic, immunohistochemical, and molecular assessment are essential. Rapid progression despite docetaxel plus pembrolizumab indicates that programmed death-ligand 1 positivity alone may not reliably predict immunotherapy benefit, while the clinical significance of rare KRAS\/NRAS co-mutations remains uncertain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050150","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:01:05Z","timestamp":1786730465000},"page":"e50150","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary sarcomatoid carcinoma in the anterior mediastinum mimicking thymic carcinoma with rapid widespread metastases"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3699-0614","authenticated-orcid":false,"given":"Linru","family":"Zhong","sequence":"first","affiliation":[{"name":"Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Chai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhejiang Hospital, Hangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Lin","sequence":"additional","affiliation":[{"name":"Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensuo","family":"Yang","sequence":"additional","affiliation":[{"name":"Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Zhejiang Hospital, Hangzhou, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhai","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Zhejiang Hospital, Hangzhou, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.surg.2012.05.007","article-title":"Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results database analysis.","volume":"152","author":"Yendamuri","year":"2012","journal-title":"Surgery"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cllc.2016.11.016","article-title":"Pulmonary sarcomatoid carcinoma: an analysis of the national cancer database.","volume":"18","author":"Steuer","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015.","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"R4-20260817","first-page":"e16935","article-title":"Report of two pulmonary sarcomato\u00efd carcinoma cases with highlights on the computed tomography features.","volume":"13","author":"Aichouni","year":"2021","journal-title":"Cureus"},{"key":"R5-20260817","first-page":"131","article-title":"Approaches to tumor classification in pulmonary sarcomatoid carcinoma.","volume":"10","author":"Baldovini","year":"2019","journal-title":"Lung Cancer (Auckl)"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"1758835920950207","DOI":"10.1177\/1758835920950207","article-title":"Pulmonary sarcomatoid carcinoma: progress, treatment and expectations.","volume":"12","author":"Li","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1200\/JCO.2017.74.9523","article-title":"Carcinosarcomas and related cancers: tumors caught in the act of epithelial-mesenchymal transition.","volume":"36","author":"Pang","year":"2018","journal-title":"J Clin Oncol"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"635","DOI":"10.21037\/tlcr-24-127","article-title":"Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review.","volume":"13","author":"Wei","year":"2024","journal-title":"Transl Lung Cancer Res"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1038\/s41467-020-18702-3","article-title":"Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma.","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jtho.2017.03.005","article-title":"Pulmonary sarcomatoid carcinomas commonly harbor either potentially targetable genomic alterations or high tumor mutational burden as observed by comprehensive genomic profiling.","volume":"12","author":"Schrock","year":"2017","journal-title":"J Thorac Oncol"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"e70213","DOI":"10.1002\/rcr2.70213","article-title":"Pulmonary sarcomatoid carcinoma initially misdiagnosed as aspergillosis: a diagnostic challenge.","volume":"13","author":"Qian","year":"2025","journal-title":"Respirol Case Rep"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"e27813","DOI":"10.1097\/MD.0000000000027813","article-title":"Pulmonary sarcomatoid carcinoma mimicking pleural mesothelioma: a case report.","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"1567046","DOI":"10.3389\/fmed.2025.1567046","article-title":"Case report: cracking the case: unique presentation of pulmonary sarcomatoid carcinoma with spherical lung metastases.","volume":"12","author":"Liu","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"833486","DOI":"10.3389\/fonc.2022.833486","article-title":"Characteristics and prognostic analysis of 55 patients with pulmonary sarcomatoid carcinoma.","volume":"12","author":"Sun","year":"2022","journal-title":"Front Oncol"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.humpath.2013.09.005","article-title":"Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma \u2013 sensitivity of TTF-1 is superior to napsin.","volume":"45","author":"Terra","year":"2014","journal-title":"Hum Pathol"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15587\/2519-4798.2020.199841","article-title":"Morphometric and immunohistochemical features of TTF-1 positive lung tumors: improvement of approaches to the diagnosis of unknown primary sites metastases.","volume":"0","author":"Poslavska","year":"2020","journal-title":"ScienceRise: Med Sci"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13019-024-02712-z","article-title":"A basaloid carcinoma with multilocular thymic cyst mimicking a mediastinal teratoma.","volume":"19","author":"Su","year":"2024","journal-title":"J Cardiothorac Surg"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2147\/OTT.S96834","article-title":"The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations.","volume":"9","author":"Zheng","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.3390\/cancers14174103","article-title":"Molecular biology and therapeutic perspectives for K-Ras mutant non-small cell lung cancers.","volume":"14","author":"Cekani","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/PO.21.00223","article-title":"KRAS A146 mutations are associated with distinct clinical behavior in patients with colorectal liver metastases.","volume":"5","author":"van \u2018t Erve","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"101978","DOI":"10.1016\/j.ctrv.2020.101978","article-title":"KRAS as a druggable target in NSCLC: rising like a phoenix after decades of development failures.","volume":"85","author":"Friedlaender","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10120-024-01468-8","article-title":"Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models.","volume":"27","author":"Puliga","year":"2024","journal-title":"Gastric Cancer"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/medicina57101039","article-title":"Evaluation of KRAS concomitant mutations in advanced lung adenocarcinoma patients.","volume":"57","author":"Aran","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/jmp1010006","article-title":"Concomitant rare KRAS and BRAF mutations in lung adenocarcinoma: a case report.","volume":"1","author":"Iaccarino","year":"2020","journal-title":"JMP"},{"key":"R25-20260817","first-page":"480","article-title":"Advances in immunotherapy for pulmonary sarcomatoid carcinoma.","volume":"47","author":"Wei","year":"2024","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2217\/fon-2021-1071","article-title":"The treatment of advanced pulmonary sarcomatoid carcinoma.","volume":"18","author":"Zheng","year":"2022","journal-title":"Future Oncol"},{"key":"R27-20260817","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3390\/cancers15092469","article-title":"Demographics and clinicopathologic profile of pulmonary sarcomatoid carcinoma with survival analysis and genomic landscape.","volume":"15","author":"Ullah","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ejcts\/ezx417","article-title":"Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results database.","volume":"53","author":"Rahouma","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"R29-20260817","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1159\/000492666","article-title":"Nivolumab-induced impressive response of refractory pulmonary sarcomatoid carcinoma with brain metastasis.","volume":"11","author":"Salati","year":"2018","journal-title":"Case Rep Oncol"},{"key":"R30-20260817","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1159\/000507568","article-title":"Dramatic response of pulmonary sarcomatoid carcinoma to nivolumab combined with anlotinib: a case report.","volume":"13","author":"Jin","year":"2020","journal-title":"Case Rep Oncol"},{"key":"R31-20260817","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.annonc.2024.06.014","article-title":"Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer.","volume":"35","author":"Di Federico","year":"2024","journal-title":"Ann Oncol"},{"key":"R32-20260817","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.lungcan.2021.07.015","article-title":"Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors.","volume":"159","author":"Yoh","year":"2021","journal-title":"Lung Cancer"},{"key":"R33-20260817","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3389\/fonc.2020.00588","article-title":"Editorial: oncogenic RAS-dependent reprogramming of cellular plasticity.","volume":"10","author":"Konstantinidou","year":"2020","journal-title":"Front Oncol"},{"key":"R34-20260817","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.3390\/cancers15133372","article-title":"Heterogeneous expression of PD-L1, B7x, B7-H3, and HHLA2 in pulmonary sarcomatoid carcinoma and the related regulatory signaling pathways.","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R35-20260817","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1002\/cai2.112","article-title":"Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes.","volume":"3","author":"Seth","year":"2024","journal-title":"Cancer Innov"},{"key":"R36-20260817","doi-asserted-by":"crossref","first-page":"893","DOI":"10.21037\/jtd-20-2826","article-title":"Clinicopathological features and prognostic analysis of metastatic pulmonary sarcomatoid carcinoma: a SEER analysis.","volume":"13","author":"Xiao","year":"2021","journal-title":"J Thorac Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:00:11Z","timestamp":1786982411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050150"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":36,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050150","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2026-01-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}